Belimumab therapy for refractory immune thrombocytopenia in systemic lupus erythematosus patients with anti-phospholipid antibodies

Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke

(2021) Laura Naranjo et al.   Frontiers in Cardiovascular Medicine

Development of New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

(2020) Medha Barbhaiya et al.   ARTHRITIS CARE & RESEARCH

Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis

(2019) Yu Pei Chock et al.   AUTOIMMUNITY REVIEWS

Effect of belimumab treatment on antiphospholipid antibodies levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

(2019) Katerina Chatzidionysiou et al.   ANNALS OF THE RHEUMATIC DISEASES

Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus

(2019) N. Jiang et al.   PLoS One

Antiphospholipid syndrome

(2019) Lisa R. Sammaritano   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab

(2018) Savino Sciascia et al.   ANNALS OF THE RHEUMATIC DISEASES

Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

(2016) Luis A. González-Naranjo et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM